SCHEMBL9602243

SCHEMBL9602243

CCCCCCNc1c(N)cnc2ccccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR2 O95136 1/20 0.57
LMNA P02545 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
SLC2A1 P11166 6/20 0.52
HRH3 Q9Y5N1 2/20 0.49
ELANE P08246 2/20 0.46
CACNA2D1 P54289 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA1D P25100 1/20 0.46
ADRA1A P35348 1/20 0.46
ADRA1B P35368 1/20 0.46
GBA1 P04062 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
ACP1 P24666 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31197371 1.00 S1PR2 (0.57) S1PR2LMNASMN1; SMN2NPSR1SLC2A1
SCHEMBL10589295 1.00 S1PR2 (0.57) S1PR2LMNASMN1; SMN2NPSR1SLC2A1
SCHEMBL5118839 0.94 S1PR2 (0.49) S1PR2LMNASMN1; SMN2NPSR1SLC2A1
SCHEMBL6096807 0.93 HTR1A (0.51) SLC2A1HRH3HTR1AADRA1DADRA1A
SCHEMBL18843434 0.88 APP (0.50) S1PR2LMNASMN1; SMN2NPSR1SLC2A1
SCHEMBL6787115 0.86 HRH3 (0.45) SLC2A1HRH3CACNA2D1HTR1AADRA1D
SCHEMBL6411140 0.85 HRH3 (0.46) S1PR2LMNASMN1; SMN2NPSR1SLC2A1
SCHEMBL4313700 0.84 POLB (0.57) LMNASMN1; SMN2SLC2A1HRH3CACNA2D1
SCHEMBL7218710 0.84 POLB (0.45) LMNASLC2A1HRH3CACNA2D1HTR1A
SCHEMBL4336578 0.83 POLB (0.44) LMNASLC2A1HRH3CACNA2D1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0310950-B1 Quinoline intermediates for the synthesis of 1H-imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amimes RIKER LABORATORIES, INC. (US) 1993-01-13 EP disclosed
EP-0145340-B1 1H-Imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amines RIKER LABORATORIES, INC. (US) 1990-01-24 EP disclosed
EP-0310950-A1 Quinoline intermediates for the synthesis of 1H-imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amimes RIKER LABORATORIES, INC. (US) 1989-04-12 EP disclosed
US-4698348-A 1H-imidazo[4,5-c]quinolines and their use as bronchodilating agents RIKER LABORATORIES, INC. (US) 1987-10-06 US disclosed
US-4689338-A 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use RIKER LABORATORIES, INC. (US) 1987-08-25 US disclosed
EP-0145340-A2 1H-Imidazo[4,5-c]quinolines and 1H-imidazo[4,5-c]quinolin-4-amines RIKER LABORATORIES, INC. (US) 1985-06-19 EP disclosed